Figure 4 from Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer
<p>Pharmacodynamic analyses. <b>A,</b> Multiplex IHC of archival tumor tissue from one patient with disease progression and one patient with PR; <b>B,</b> Percent change (cycle 3 day 1 compared with baseline) in peripheral blood effector CD4<sup>+</sup> (CD4...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Drugi avtorji: | , , , , , , , , , , , , , , , , , , , , , |
| Izdano: |
2025
|
| Teme: | |
| Oznake: |
Označite
Brez oznak, prvi označite!
|